CDSCO Approves Wegovy as India's First Injectable GLP-1 Drug for Fatty Liver Disease MASH
The Central Drugs Standard Control Organisation (CDSCO) has approved Wegovy as India's first injectable Glucagon-Like Peptide-1 (GLP-1) receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatit...